Efficacy and safety evaluation of once-daily fluticasone furoate/vilanterol in Asian patients with asthma uncontrolled on a low- to mid-strength inhaled corticosteroid or low-dose inhaled corticosteroid/long-acting beta2-agonist-Reference-Cited by-同舟云学术

Efficacy and safety evaluation of once-daily fluticasone furoate/vilanterol in Asian patients with asthma uncontrolled on a low- to mid-strength inhaled corticosteroid or low-dose inhaled corticosteroid/long-acting beta2-agonist

Published:2016-07-01 Issue:4 Volume:37 Page:302-310
ISSN:1088-5412
Container-title:Allergy and Asthma Proceedings
language:en
Short-container-title:allergy asthma proc

Author:

Lin Jiangtao¹,Tang Huaping,Chen Ping,Wang Haoyan,Kim Mi-Kyeong,Crawford Jodie,Jacques Loretta,Stone Sally

Affiliation:

1. Department of Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China

Publisher

Oceanside Publications Inc.

Subject

Pulmonary and Respiratory Medicine,General Medicine,Immunology and Allergy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma and/or Chronic Obstructive Pulmonary Disease: A Post-Marketing Study in Korea;Drug Safety;2023-08-31

2. Correlation Meta-Analysis of the Efficacy of Inhaled Corticosteroids in Children with Asthma Based on Smart Medical Health;Journal of Healthcare Engineering;2022-04-13

3. Longitudinal Model‐Based Meta‐Analysis of Lung Function Response to Support Phase III Study Design in Chinese Patients With Asthma;Clinical Pharmacology & Therapeutics;2022-04-07

4. The safety of long-term use of inhaled corticosteroids in patients with asthma: A systematic review and meta-analysis;Clinical Immunology;2022-03

5. Asthma phenotypes and T-bet protein expression in cells treated with Fluticasone Furoate/Vilanterol;Pulmonary Pharmacology & Therapeutics;2020-02